EMILY HODGES: Open Payments
NPI 1023716693 · MAUMELLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 54 payments from 21 companies in 2025. Trend: 2023 $1,732 · 2024 $1,693 · 2025 $1,839
Food & beverage: $1,839
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $209 |
| GlaxoSmithKline, LLC. | 6 | $177 |
| Amgen Inc. | 5 | $166 |
| Corcept Therapeutics | 2 | $147 |
| Stryker Corporation | 2 | $146 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $124 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Dexcom, Inc. | 1 | $122 |
| Kowa Pharmaceuticals America, Inc. | 6 | $101 |
Products named: Korlym, MAKO, VOQUEZNA, EVENITY, TZIELD, Auvelity, Dexcom G6 Transmitter, SHINGRIX.
Industry payments across AR — which companies pay providers there.
